The nation of Zimbabwe has rejected a significant US health deal worth 367 million US dollars (£272m) spanning five years because of Washington's request for sensitive data.
The decision became public after a government memo dated December was leaked, which showed President Emmerson Mnangagwa felt the agreement was "unbalanced".
A government representative later stated that the US was requesting genetic material for scientific study and commercial gain but refused to share the resulting advantages from any future medical innovations.
"We must now begin the difficult and regrettable task of ending our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had provided over $1.9bn in health funding to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has called for further talks to secure a deal suitable to all parties so the country's critical HIV programme can be sustained.
Broader Background
This rejection comes after a similar situation in Kenya, where a court blocked a similar health funding agreement after legal challenges were filed about the security of citizens' health data.
Since resuming the presidency last year, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.
USAID had managed assistance for the American government, but Trump claimed its spending was "wasteful" and his government was seeking government-to-government deals to enhance transparency and responsibility.
As per statements, Sixteen nations in Africa have so far agreed to these new agreements, representing more than $18.3bn in new funding.
Specifics of the Declined Agreement
The money for Zimbabwe would have funded "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this collaboration might have yielded immense benefits for the people of Zimbabwe, particularly the 1.2 million presently on antiretroviral therapy via American-funded programmes," the Ambassador added.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unequal".
"Zimbabwe was being asked to share its biological resources and data indefinitely, with no equivalent promise of access to any scientific breakthroughs – such as new medicines or tests – that could be developed from that shared data," his statement read.
"In essence, our country would provide the basic resources for scientific discovery without any assurance that the resulting innovations would be accessible to our citizens should a future health crisis arise."
National Interest and International Frameworks
He also noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were undermining systems already established through the international health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme designed to manage potential global health emergencies.
"This mechanism is intended to guarantee that when a country contributes its samples, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised solely by those with the resources to create them."
The government's concerns over the US deal "must not be interpreted as hostility towards the US," he added.
"We welcome further discussions with our American counterparts on how subsequent co-operation might be designed in a way that honours the sovereignty and interests of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the official position, but recommended that talks should continue given that a large portion of the nation's Aids initiatives depended on foreign aid.
"Where specific concerns arise, including those relating to data governance or implementation frameworks, these can often be addressed via technical clarification and mutually agreed protections," the group added.
This impasse underscores the continuing challenges between accepting vital foreign assistance and safeguarding national sovereignty in an increasingly interconnected world.